ORWH Funding Friday
December 27, 2024
Welcome to ORWH’s “Funding Friday,” a bimonthly email featuring notices of funding opportunities (NOFOs) and research that ORWH is directly supporting or otherwise providing funding for. You’ll find NOFOs and notices from other NIH Institutes, Centers, and Offices (ICOs), as well as other agencies across the U.S. Department of Health and Human Services (HHS). All notices featured relate to the health of women, women in biomedical careers, and/or the study of sex and gender. Please take extra care when reviewing the submission criteria and deadlines for each NOFO as many announcements have multiple deadlines.
Notice of Special Interest (NOSI): Women’s Health Research (NOT-OD-24-079) Submission dates vary by awarding NIH Institute or Center Contacts
In alignment with the White House Initiative on Women’s Health Research, ORWH has released a new NOSI to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause). The NOSI will serve as a dedicated, one-stop shop that centralizes all existing funding opportunities across each of NIH’s 27 institutes that align with women's health research interests.
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (PA-24-247), (PA-24-248)
Due dates: January 5, 2025
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications
(PA-24-245), (PA-24-246)
Due dates: January 5, 2025
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (PAR-25-213), (PAR-25-223)
First available due dates: January 7, 2025
NOSI: Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-24-179)
First available due date: January 22, 2025
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01/R34 Clinical Trials Required) (RFA-DA-26-003), (RFA-DA-26-004)
Earliest Submission Date: February 12, 2025
Notice of ORWH participation in NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (PAR-23-183)
Application due date: February 26, 2025
NOSI: Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative (NOT-HD-22-043) Expiration date: May 7, 2025
Enhancing Mechanistic Research on Precision Probiotic Therapies
(R33 Clinical Trial Optional) (PAR-25-210)
First available due date: June 2, 2025
NOSI: Health Influences of Gender as a Social and Structural Variable (NOT-OD-24-038)
Expiration date: October 1, 2025
NOSI: Autoimmune Inner Ear Disease (Clinical Trials Not Allowed) (NOT-DC-25-003) Submission dates follow the NIH standard due dates
Expiration date: October 17, 2027
NOSI: Research Opportunities Centering the Health of Women Across the HIV Research Continuum (NOT-OD-24-119)
Submission dates vary by awarding NIH Institute or Center Contacts
Visit ORWH’s full list of sponsored funding opportunities and notices. We encourage you to explore the websites of the many ICs across NIH to stay up to date on the latest grants and funding information. You can also visit the NIH Grants & Funding website and subscribe to the NIH Guide.
|
